IP Library › Granted Patent US 12,343,289
Granted Patent B2
US 12,343,289 · App. 18/249,009 · Granted Jul 1, 2025

Spatial light modulation targeting of therapeutic lasers for treatment of ophthalmological conditions

Inventors: Nir Katchinskiy (Alberta, CA); Abdulhakem Elezzabi (Alberta, CA)
Assignee: Pulsemedica Corp.
A61F9/008A61B3/102A61B2017/00159A61F2009/00851
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,343,289
App. No.
18/249,009
Filed
Apr 13, 2023
Granted
Jul 1, 2025
Kind
B2
Examiner
LUAN, SCOTT
Art Unit
3792
USPC
606/4
Abstract

A therapeutic laser for use in treating ophthalmological conditions can be modulated by a spatial light modulation device in order to focus the therapeutic laser on a plurality of target locations simultaneously.

Claims (32)

1. A therapeutic laser delivery system for ophthalmology comprising:

an imaging system comprising at least one of: a scanning laser ophthalmoscopy (SLO) system comprising a SLO detector and a SLO light source, wherein the SLO light source is configured to generate light for passing from the SLO light source through an SLO optical pathway for SLO imaging, or an optical coherence tomography (OCT) system comprising an OCT detector and an OCT light source, wherein the OCT light source is configured to generate light for passing from the OCT light source through an OCT optical pathway for OCT imaging;

a therapeutic laser configured to generate a therapeutic laser light for passing through a therapeutic laser delivery optical path and delivering at least a portion of the therapeutic laser light to an ophthalmological target;

a spatial light modulator (SLM) device arranged in the therapeutic laser delivery optical path to modulate the therapeutic laser light, wherein the SLM device is configured to split the therapeutic laser light into a plurality of therapeutic laser light beams for simultaneous delivery of the therapeutic laser light beams to a plurality of target locations; and

at least one processor for determining the plurality of target locations and controlling the SLM device to modulate the therapeutic laser light for treatment of floaters in a vitreous humour of the ophthalmological target,

wherein the SLM device is configured to control one or more characteristics of the therapeutic laser light to adapt the therapeutic laser light for increased coverage of or application to the floaters for treatment in the vitreous humour, the one or more characteristics being at least one of: a shape, a lightwave phase, a lightwave polarization, a wavefront tilt, a diffraction, a wavefront helicity, and an orbital angular momentum order.

2. The system of claim 1 , further comprising:

a targeting laser configured to generate a targeting laser light for passing through a targeting laser delivery optical path and delivering the targeting laser light to the ophthalmological target, wherein the SLM device is further arranged to modulate the targeting laser light and split the targeting laser light into a plurality of targeting laser light beams for simultaneous delivery of the targeting laser light beams to the plurality of target locations.

3. The system of claim 2 , wherein the targeting laser delivery optical path comprises an alignment optical path for aligning and inputting the targeting laser light to the therapeutic laser delivery optical path.

4. The system of claim 2 , wherein the imaging system is configured to capture an image of the ophthalmological target.

5. The system of claim 4 , wherein the image captured by the imaging system captures the plurality of targeting laser light beams delivered by the SLM device.

6. The system of claim 4 , wherein the captured image is processed to compare the plurality of targeting laser light beams delivered by the SLM device to the plurality of target locations.

7. The system of claim 6 , wherein the comparing of the plurality of targeting laser light beams captured in the image to the plurality of target locations is used as feedback for controlling the SLM device.

8. The system of claim 1 , further comprising a fundus camera system.

9. The system of claim 1 , wherein the imaging system comprises a tracking system for tracking eye movement.

10. The system of claim 1 , wherein the determined plurality of target locations comprise a plurality of simultaneous treatment locations for the therapeutic laser light.

11. The system of claim 10 , wherein the SLM device is controlled to deliver a portion of the therapeutic laser light on each of the plurality of simultaneous treatment locations simultaneously.

12. The system of claim 11 , wherein the portion of the therapeutic laser light delivered on each of the plurality of simultaneous treatment locations has a respective power.

13. The system of claim 12 , wherein the respective power of the portion of the therapeutic laser light delivered on one of the plurality of simultaneous treatment locations differs from the respective power of another one of the plurality of simultaneous treatment locations.

14. The system of claim 1 , wherein the at least one processor is further configured to control the SLM device to shape a pulse of the therapeutic laser light.

15. The system of claim 1 , wherein the SLM device comprises one or more of: a liquid crystal-based SLM device, a microelectromechanical micromirror-based SLM device, a membrane mirror-based SLM device, an active metasurface, or a passive metasurface.

16. The system of claim 1 , wherein the plurality of target locations are located in one or more of: a sclera of the ophthalmological target, an iris of the ophthalmological target, a pupil of the ophthalmological target, a cornea of the ophthalmological target, a retina of the ophthalmological target, or a vitreous humour of the ophthalmological target.

17. The system of claim 1 , wherein the delivery of the plurality of therapeutic laser light beams to the plurality of target locations is used to treat one or more of: diabetic retinopathy, age-related macular degeneration, vitreomacular traction, tears, retinal detachments, holes, glaucoma, vein occlusion, choroidal detachment, diabetic macular edema, posterior vitreous detachment, cataracts, floaters, or dry eye.

18. The system of claim 1 , wherein the plurality of target locations are all located on a single floater in the ophthalmological target.

19. A method of targeting a therapeutic laser on an ophthalmological target comprising:

determining a plurality of target locations for receiving targeting laser light beams;

controlling a spatial light modulation (SLM) device to split a targeting laser light into a plurality of targeting laser light beams and simultaneously deliver the targeting laser light beams to the plurality of determined target locations;

capturing an image of the plurality of targeting laser light beams delivered to the plurality of determined target locations;

comparing locations of the plurality of targeting laser light beams captured in the image to the plurality of determined target locations;

controlling the SLM device based on feedback from the comparing of the locations of the plurality of targeting laser light beams captured in the image to the plurality of determined target locations;

delivering a plurality of therapeutic laser light beams to the plurality of target locations, wherein the SLM device is configured receive therapeutic laser light and to split the therapeutic laser into the plurality of therapeutic laser light beams.

20. The method of claim 19 , wherein the image is captured using at least one of: an optical coherence tomography system, a fundus camera, or a scanning laser ophthalmoscopy (SLO) system.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 31, 2023
From: KATCHINSKIY, NIR; ELEZZABI, ABDULHAKEM
To: PULSEMEDICA CORP.
Reel/Frame 065410/0452 →
Priority Claims (1)
CA CA 3100460 · Nov 24, 2020 · national
Continuity (1)
Related Publication 20230381022A1 · Nov 30, 2023
References Cited (109)
US 7805009B2 · Everett et al. · 2010 [cited by applicant]
US 7980696B1 · Taki et al. · 2011 [cited by applicant]
US 9550069B1 · Elezzabi · 2017 [cited by applicant]
US 10117576B2 · De et al. · 2018 [cited by applicant]
US 10694939B2 · Kuo et al. · 2020 [cited by applicant]
US 20040174495A1 · Levine · 2004 [cited by applicant]
US 20040254567A1 · Holz et al. · 2004 [cited by applicant]
US 20070046948A1 · Podoleanu et al. · 2007 [cited by applicant]
US 20070115481A1 · Toth et al. · 2007 [cited by applicant]
US 20090093798A1 · Charles · 2009 [cited by applicant]
US 20100094135A1 · Fang-Yen et al. · 2010 [cited by applicant]
US 20100182610A1 · Utsunomiya · 2010 [cited by applicant]
US 20100290007A1 · Van de Velde · 2010 [cited by applicant]
US 20110009779A1 · Romano et al. · 2011 [cited by applicant]
US 20110043661A1 · Podoleanu · 2011 [cited by applicant]
US 20110058175A1 · Suehira · 2011 [cited by applicant]
US 20110134436A1 · Podoleanu et al. · 2011 [cited by applicant]
US 20110234978A1 · Hammer et al. · 2011 [cited by applicant]
US 20110301508A1 · Sethuraman et al. · 2011 [cited by applicant]
US 20120002164A1 · Yamamoto et al. · 2012 [cited by applicant]
US 20120154747A1 · Makihira · 2012 [cited by applicant]
US 20120165799A1 · Yamamoto · 2012 [cited by applicant]
US 20120274904A1 · Saito et al. · 2012 [cited by applicant]
US 20120294500A1 · Utsunomiya et al. · 2012 [cited by applicant]
US 20130286348A1 · Makihira et al. · 2013 [cited by applicant]
US 20140104618A1 · Potsaid et al. · 2014 [cited by applicant]
US 20140194860A1 · Dick et al. · 2014 [cited by applicant]
US 20150116664A1 · Uchida · 2015 [cited by applicant]
US 20150141972A1 · Woodley et al. · 2015 [cited by applicant]
US 20150305617A1 · Tachikawa et al. · 2015 [cited by applicant]
US 20160022490A1 · Ergun et al. · 2016 [cited by applicant]
US 20160074221A1 · Tassignon et al. · 2016 [cited by applicant]
US 20160250067A1 · Iwata et al. · 2016 [cited by applicant]
US 20160284103A1 · Huang · 2016 [cited by applicant]
US 20170007112A1 · Gonzalez · 2017 [cited by applicant]
US 20170035291A1 · Jiao et al. · 2017 [cited by applicant]
US 20170132826A1 · Grady et al. · 2017 [cited by applicant]
US 20170189228A1 · Yang et al. · 2017 [cited by applicant]
US 20170310901A1 · Sheikh et al. · 2017 [cited by applicant]
US 20170360411A1 · Rothberg et al. · 2017 [cited by applicant]
US 20180101644A1 · Hammes et al. · 2018 [cited by applicant]
US 20180111008A1 · Chapuis et al. · 2018 [cited by applicant]
US 20180116502A1 · Ishinabe · 2018 [cited by applicant]
US 20180200112A1 · Krampert et al. · 2018 [cited by applicant]
US 20180271362A1 · Palczewski et al. · 2018 [cited by applicant]
US 20180344150A1 · Bajraszewski et al. · 2018 [cited by applicant]
US 20180353064A1 · Soetikno et al. · 2018 [cited by applicant]
US 20190000316A1 · Hirose et al. · 2019 [cited by applicant]
US 20190038766A1 · Mohanty · 2019 [cited by examiner]
US 20190099291A1 · Herekar et al. · 2019 [cited by applicant]
US 20190114804A1 · Sundaresan et al. · 2019 [cited by applicant]
US 20190125178A1 · Murata · 2019 [cited by applicant]
US 20190130580A1 · Chen et al. · 2019 [cited by applicant]
US 20190188851A1 · Zouridakis · 2019 [cited by applicant]
US 20190278972A1 · Anderson et al. · 2019 [cited by applicant]
US 20190332900A1 · Sjolund et al. · 2019 [cited by applicant]
US 20190339356A1 · Schildknecht et al. · 2019 [cited by applicant]
US 20200015675A1 · Shibutani et al. · 2020 [cited by applicant]
US 20200160301A1 · Lyman et al. · 2020 [cited by applicant]
US 20200194108A1 · Podilchuk et al. · 2020 [cited by applicant]
US 20200218943A1 · Osake · 2020 [cited by applicant]
US 20200242768A1 · Ashok et al. · 2020 [cited by applicant]
US 20200245960A1 · Richter et al. · 2020 [cited by applicant]
US 20200250436A1 · Lee et al. · 2020 [cited by applicant]
US 20200285906A1 · Do et al. · 2020 [cited by applicant]
US 20200288973A1 · Ono · 2020 [cited by applicant]
US 20200294654A1 · Harzig et al. · 2020 [cited by applicant]
US 20210045672A1 · Jia et al. · 2021 [cited by applicant]
US 20210142487A1 · Xu et al. · 2021 [cited by applicant]
US 20210186753A1 · Al-Qaisi et al. · 2021 [cited by applicant]
US 20210202062A1 · Gray et al. · 2021 [cited by applicant]
US 20210224997A1 · Kushida et al. · 2021 [cited by applicant]
US 20220117780A1 · Zhang · 2022 [cited by applicant]
US 20220151483A1 · Ono et al. · 2022 [cited by applicant]
US 20220390369A1 · Piestun et al. · 2022 [cited by applicant]
US 20230372153A1 · Katchinskiy et al. · 2023 [cited by applicant]
US 20240016660A1 · Katchinskiy et al. · 2024 [cited by applicant]
CA 2714116A1 · 2009 [cited by applicant]
CA 3096285A1 · 2022 [cited by applicant]
CA 3157811A1 · 2023 [cited by applicant]
CN 109938919A · 2019 [cited by applicant]
CN 114511738A · 2022 [cited by applicant]
CN 117788881A · 2024 [cited by applicant]
EP 1401326A2 · 2004 [cited by applicant]
EP 2403603B1 · 2014 [cited by applicant]
FR 3121535A1 · 2022 [cited by applicant]
JP 2015195923A · 2015 [cited by applicant]
JP 2017184874A · 2017 [cited by applicant]
KR 1020190130310A · 2019 [cited by applicant]
WO 2016011045A1 · 2016 [cited by applicant]
WO 2020020809A1 · 2020 [cited by applicant]
WO 2020012841A1 · 2020 [cited by applicant]
WO 2020058459A1 · 2020 [cited by applicant]
WO 2020215359A1 · 2020 [cited by applicant]
WO 2020227661A1 · 2020 [cited by applicant]
WO 2021029231A1 · 2021 [cited by applicant]
WO 2021069168A1 · 2021 [cited by applicant]
WO 2021069220A1 · 2021 [cited by applicant]
WO 2021122762A1 · 2021 [cited by applicant]
WO 2022077117A1 · 2022 [cited by applicant]
WO 2022133590A1 · 2022 [cited by applicant]
WO 2023065042A1 · 2023 [cited by applicant]
WO 2023212825A1 · 2023 [cited by applicant]
International Search Report for International Application No. PCT/CA2021/051451, mailed Dec. 20, 2021, 4 pages. [cited by applicant]
Non-Final Office Action on related U.S. Appl. No. 18/475,558, dated Nov. 7, 2023. [cited by applicant]
International Search Report for International Application No. PCT/CA2021/051659, mailed Jan. 27, 2022, 2 pages. [cited by applicant]
Gomez, A., et al., “Image Reconstruction in a Manifold of Image Patches: Application to Whole-Fetus Ultrasound Imaging”, Machine Learning for Medical Image Reconstruction, Oct. 24, 2019, pp. 226-235. [cited by applicant]
Kaplan, S., et al., “Contrastive Learning for Generating Optical Coherence Tomography Images of the Retina”; Simulation and Synthesis in Medical Imaging, Sep. 21, 2022, pp. 112-121. [cited by applicant]
Tam, Johnny and Yang, Qiang; “Optics Retinal Imaging with Eye Tracking”; found at: Adaptive Optics Retinal Imaging with Eye Tracking, National Institute of Biomedical Imaging and Bioengineering (nib.gov). [cited by applicant]
Cited By (2)
US 12,589,032 US 12,670,587